SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-007727 to JBS N.V. (JBS)

JBS N.V.
Date: July 20, 2023 · CIK: 0001791942 · Accession: 0000000000-23-007727

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-273211

Date
July 20, 2023
Author
Beverly Singleton
Form
UPLOAD
Company
JBS N.V.

Letter

United States securities and exchange commission logo July 20, 2023 Gilberto Tomazoni Chief Executive Officer JBS B.V. Stroombaan 16, 5th Floor 1181 VX, Amstelveen, Netherlands Re:JBS B.V. Registration Statement on Form F-4 Filed July 12, 2023 File No. 333-273211 Dear Gilberto Tomazoni: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Registration Statement on Form F-4 General 1.We note that Article 38 of the Articles of Association filed as Exhibit 3.2 identifies the federal district courts of the United States as the exclusive forum for actions arising under the Securities Act. Please include disclosure regarding this forum selection provision, including whether it applies to actions arising under the Exchange Act. In that regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Please also revise your prospectus to state that there is uncertainty as to whether a court would enforce such

FirstName LastNameGilberto Tomazoni Comapany NameJBS B.V. July 20, 2023 Page 2 FirstName LastName Gilberto Tomazoni JBS B.V. July 20, 2023 Page 2 provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. If this provision does not apply to actions arising under the Exchange Act, please also ensure that the exclusive forum provision in the governing documents states this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Exchange Act. Exhibits 2.Please request counsel to revise the legal opinion filed as Exhibit 5.1 to clearly opine as to all the shares being registered. In this regard, we note that your Form F-4 registers 345,681,599 Class B shares, while the opinion refers to 450,000 existing Class B shares and an unspecified number of new Class B shares to be issued by you and subscribed for by LuxCo. Please also request counsel to remove the inappropriate limitations in paragraphs 4.4 and 4.5. 3.Please request counsel to revise paragraphs b and c of the opinion filed as Exhibit 5.2 to clearly state that the BDSs, when sold, will be legally issued and will entitle their holders to the rights specified in the deposit agreement and the BDR. Refer to Section II.B.1.d of Staff Legal Bulletin 19 for guidance. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. You may contact Beverly Singleton at 202-551-3328 or Claire Erlanger at 202-551-3301 if you have questions regarding comments on the financial statements and related matter. Please contact Jennifer Angelini at 202-551-3047 or Geoffrey Kruczek at 202-551-3641 with any other questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: John Vetterli

Show Raw Text
United States securities and exchange commission logo
July 20, 2023
Gilberto Tomazoni
Chief Executive Officer
JBS B.V.
Stroombaan 16, 5th Floor
1181 VX, Amstelveen, Netherlands
Re:JBS B.V.
Registration Statement on Form F-4
Filed July 12, 2023
File No. 333-273211
Dear Gilberto Tomazoni:
            We have reviewed your registration statement and have the following comments.  In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Registration Statement on Form F-4
General
1.We note that Article 38 of the Articles of Association filed as Exhibit 3.2 identifies the
federal district courts of the United States as the exclusive forum for actions arising under
the Securities Act.  Please include disclosure regarding this forum selection provision,
including whether it applies to actions arising under the Exchange Act.  In that regard, we
note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all
suits brought to enforce any duty or liability created by the Exchange Act or the rules and
regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction
for federal and state courts over all suits brought to enforce any duty or liability created by
the Securities Act or the rules and regulations thereunder.  Please also revise your
prospectus to state that there is uncertainty as to whether a court would enforce such

 FirstName LastNameGilberto Tomazoni
 Comapany NameJBS B.V.
 July 20, 2023 Page 2
 FirstName LastName
Gilberto Tomazoni
JBS B.V.
July 20, 2023
Page 2
provision and that investors cannot waive compliance with the federal securities laws and
the rules and regulations thereunder.  If this provision does not apply to actions arising
under the Exchange Act, please also ensure that the exclusive forum provision in the
governing documents states this clearly, or tell us how you will inform investors in future
filings that the provision does not apply to any actions arising under the Exchange Act.
Exhibits
2.Please request counsel to revise the legal opinion filed as Exhibit 5.1 to clearly opine as to
all the shares being registered.  In this regard, we note that your Form F-4 registers
345,681,599 Class B shares, while the opinion refers to 450,000 existing Class B shares
and an unspecified number of new Class B shares to be issued by you and subscribed for
by LuxCo.  Please also request counsel to remove the inappropriate limitations in
paragraphs 4.4 and 4.5.
3.Please request counsel to revise paragraphs b and c of the opinion filed as Exhibit 5.2 to
clearly state that the BDSs, when sold, will be legally issued and will entitle their holders
to the rights specified in the deposit agreement and the BDR.  Refer to Section II.B.1.d
of Staff Legal Bulletin 19 for guidance.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration.  Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            You may contact Beverly Singleton at 202-551-3328 or Claire Erlanger at 202-551-3301
if you have questions regarding comments on the financial statements and related matter.  Please
contact Jennifer Angelini at 202-551-3047 or Geoffrey Kruczek at 202-551-3641 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:       John Vetterli